Paolo Bergamo

Paolo Bergamo is a Researcher at the Institute of Biosciences and BioResources (IBBR) of the National Research Council of Italy (CNR) in Naples, a position held since 2021. Previously, he served as a Researcher at the CNR Institute of Food Sciences (ISA) in Avellino (2003-2021) and the CNR Institute for the Animal Production System in the Mediterranean Environment (ISPAAM) (1993-2002).

His academic foundation includes:

• Bachelor in Biological Science, University of Naples "Federico II" (1987, summa cum laude)
• Postgraduate training, Stazione Zoologica "Anton Dohrn" (1987-1989)
• CNR fellowship, ISPAAM (1990-1991)

Bergamo's research centers on dietary bioactives' modulation of redox homeostasis, with emphasis on conjugated linoleic acid (CLA), plant extracts, and fatty acids. He investigates their impact on the Nrf2 pathway, mitochondrial function, and oxidative stress in contexts including neuroprotection, male fertility under pollution, and inflammatory bowel disease. His work bridges molecular nutrition, biochemistry, and translational health to develop dietary strategies against oxidative damage.

Analysis of his 2019-2023 publications reveals consistent exploration of Nrf2 pathway activation by dietary compounds across celiac disease models, neurodegeneration, metabolic disorders, and environmental toxicology. This cohesive theme demonstrates how nutritional interventions target oxidative stress in multiple organ systems through shared molecular mechanisms.

No scientific awards or fellowships are documented in the provided information.

While specific grant details are unlisted, Bergamo's sustained CNR research positions indicate continuous project funding. He has not formalized graduate student supervision but actively contributes as a reviewer for journals including Free Radical Biology and Medicine, PLoS One, and Journal of Leukocyte Biology. His collaborative network spans CNR divisions and international partners.

Within IBBR's Naples division, Bergamo leads laboratory investigations into diet-redox interactions, utilizing in vitro and in vivo models to study bioactive molecules' effects on cellular pathways and physiological outcomes in health and disease contexts.